AnalystsJonathan MillerJonathan Miller's Stock Forecasts
AnalystsJonathan Miller
Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4862 out of 5296 analysts
Average Return
-29.13%
Win Rate
18%2 out of 11
Risk vs Reward
Poor
Good
Jonathan Miller's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gamida Cell LtdGMDAQ | +41.85% | $4.54 | $6.44 | 2020-07-01 - 2021-07-01 | Buy |
Aura Biosciences IncAURA | +0.47% | $6.38 | $6.41 | 2025-11-26 - 2026-06-12 | Buy |
Jonathan Miller Analyst Color
Get additional color on Jonathan Miller's coverage of popular stocks
Jonathan Miller's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zymeworks IncZYME | 1 | Buy | $48.00 | +109.79% | Maintains | 3 months ago |
Caribou Biosciences IncCRBU | 1 | Buy | $13.00 | +715.05% | Maintains | 3 months ago |
Atea Pharmaceuticals IncAVIR | 1 | Buy | $10.00 | +122.72% | Maintains | 3 months ago |
Arvinas IncARVN | 1 | Buy | $19.00 | +150.66% | Maintains | 4 months ago |
Aura Biosciences IncAURA | 1 | Buy | $13.00 | +102.81% | Reinstates | 7 months ago |
Intellia Therapeutics IncNTLA | 1 | Hold | $8.00 | -33.94% | Downgrades | 7 months ago |
Prokidney CorpPROK | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Vaxxinity IncVAXX | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Entrada Therapeutics IncTRDA | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Shattuck Labs IncSTTK | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Sqz Biotechnologies CoSQZB | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Nanobiotix SaNBTX | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.